ProCE Banner Activity

Questions on the Optimal Use of IV Iron in Patients With HF, CKD, and IBD

Clinical Thought

Iron deficiency often is associated with chronic diseases such as heart failure, chronic kidney disease, and inflammatory bowel disease. This expert commentary answers questions from a live symposium at AMCP Nexus 2022 regarding the role of IV iron replacement in iron deficiency and accompanying chronic conditions, focusing on the economic burden of these diseases and the impact of IV iron on healthcare resource utilization.

Released: October 31, 2022

Expiration: October 31, 2023

No longer available for credit.

Share

Faculty

YuQian Liu

YuQian Liu, PharmD

Senior Director
Specialty Clinical Solutions
Magellan Rx Management
Middletown, Rhode Island

Branden D. Nemecek

Branden D. Nemecek, PharmD, BCPS

Associate Professor
Pharmacy Practice
Duquesne University
Clinical Pharmacist
University of Pittsburgh Medical Center Mercy Hospital
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Supporters

American Regent

Faculty Disclosure

YuQian Liu, PharmD, has no relevant financial relationships to disclose.

Branden D. Nemecek, PharmD, BCPS, has no relevant financial relationships to disclose.

Additional Information

Program Medium

This program has been made available online.